TREM2 sustains microglial expansion during aging and response to demyelination
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Microglia contribute to development, homeostasis, and immunity of the CNS. Like other tissue-resident macrophage populations, microglia express the surface receptor triggering receptor expressed on myeloid cells 2 (TREM2), which binds polyanions, such as dextran sulphate and bacterial LPS, and activates downstream signaling cascades through the adapter DAP12. Individuals homozygous for inactivating mutations in TREM2 exhibit demyelination of subcortical white matter and a lethal early onset dementia known as Nasu-Hakola disease. How TREM2 deficiency mediates demyelination and disease is unknown. Here, we addressed the basis for this genetic association using Trem2(-/-) mice. In WT mice, microglia expanded in the corpus callosum with age, whereas aged Trem2(-/-) mice had fewer microglia with an abnormal morphology. In the cuprizone model of oligodendrocyte degeneration and demyelination, Trem2(-/-) microglia failed to amplify transcripts indicative of activation, phagocytosis, and lipid catabolism in response to myelin damage. As a result, Trem2(-/-) mice exhibited impaired myelin debris clearance, axonal dystrophy, oligodendrocyte reduction, and persistent demyelination after prolonged cuprizone treatment. Moreover, myelin-associated lipids robustly triggered TREM2 signaling in vitro, suggesting that TREM2 may directly sense lipid components exposed during myelin damage. We conclude that TREM2 is required for promoting microglial expansion during aging and microglial response to insults of the white matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the impaired ability of Trem2−/− or Apoe−/− microglia to remove damaged myelin hinders subsequent remyelination (Cantoni et al., 2015; Cantuti-Castelvetri et al., 2018; Poliani et al., 2015; Yeh et al., 2016).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Poliani et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 signals through its binding partner DAP12 (TYROBP) to elicit responses including phagocytosis, suppression of proinflammatory response, and promoting cell survival (Poliani et al., 2015; Takahashi et al., 2005).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Poliani et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 ligands include a variety of molecules, such as bacterial wall products, Aβ oligomers, lipoproteins, and anionic lipids, such as phospholipids and sphingolipids29,32–35”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 is a phospholipid sensing receptor known to sustain microglial cell activation and expansion in response to demyelination or amyloid plaques in Alzheimer’s disease (AD) [8, 42, 50].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice lacking TREM2, fewer microglia accumulate in the corpus callosum during demyelination due to reduced proliferation which in turn reduces myelin debris clearance [200–202].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [201]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipid rafts as a membrane-organizing principle
Lingwood, D., & Simons, K. (2010) · Science · doi:10.1126/science.1174621 · Cited by 4,417 · cited 1×
“As DAP12 is located in lipid rafts, engagement of TREM2 may induce aggregation and mobilization of multiple receptors to lipid rafts (47), thereby facilitating their clustering and activation of multiple signaling pathways.”
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
Ritter, M., Schmidt, S., Jakab, M., Paulmichl, M., & Henderson, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350122 · Cited by 3,923
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 2×
“As Trem2 –/– mice did not develop spontaneous demyelination, we wanted to determine been reported in CNS cells other than microglia (33, 34), recently published studies demonstrated that Trem2 is specifically expressed in microglia — but not other cells in the CNS — under steady-state conditions…”
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“Very recent studies have shown that individuals heterozygous for a rare variant of TREM2, R47H, have high risk for developing Alzheimer disease (AD) (34, 48, 49).”
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · cited 2×
“We recently demonstrated that human TREM2 detects a similarly broad range of anionic and zwitter-ionic lipid ligands (52).”
Self-citationFatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 1×
“Very recent studies have shown that individuals heterozygous for a rare variant of TREM2 , R47H, have high risk for developing Alzheimer disease (AD) (34, 48, 49).”
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Cited by
Items 301–400 of 529
γ‐Secretase in microglia – implications for neurodegeneration and neuroinflammation
Walter, J., Kemmerling, N., Wunderlich, P., & Glebov, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14224 · Cited by 25
Jansen, M. I., Broome, S. T., & Castorina, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094788 · Cited by 21
“Following cuprizone-induced demyelination, TREM2−/− mice show reduced myelin phagocytosis and increased myelin degradation, two phenomena that in part are believed to be caused by the inability of microglia to activate lipid capture and lipid metabolism pathways [86,112].”
BackgroundBeckmann, N., Neuhaus, A., Zurbruegg, S., Volkmer, P., Patiño, C., Joller, S., Feuerbach, D., Doelemeyer, A., Schweizer, T., Rudin, S., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02671-z · Cited by 25
“TREM2 knockout (TREM2-KO) mice displayed altered microglia responses to cuprizone intoxication as well as reduced clearance of myelin debris [21, 22].”
BackgroundResultInfluentialAPOEε4 and risk of Alzheimer’s disease – time to move forward
Lefterov, I. M., Fitz, N. F., Lü, Y., & Koldamova, R. P. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1195724 · Cited by 25
“TREM2 binds myelin lipids and participates in debris clearance and remyelination (Cantoni et al., 2015; Poliani et al., 2015; Nugent et al., 2020).”
BackgroundRemyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
Current understanding on TREM-2 molecular biology and physiopathological functions
Bharadwaj, S., Groza, Y., Mierzwicka, J. M., & Malý, P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112042 · Cited by 25
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination
Hou, J., Magliozzi, R., Chen, Y., Wu, J., Wulf, J., Strout, G., Fang, X., & Colonna, M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2426786122 · Cited by 20
Self-citationWang, H., Newton, G. A., Wu, L., Lin, L., Miracco, A. S., Natesan, S., & Luscinskas, F. W. (2021) · JCI Insight · doi:10.1172/jci.insight.148719 · Cited by 21
“Our results indicate that Miap410 Ab inhibited the emergence of microglia equipped with activation markers CD11c, MHCII, and CCR2 and multiple surface receptors for removal of myelin debris, including CD64 (FcγR1); CD36, which is a scavenger receptor; TREM2, which binds lipids and promotes microglial expansion upon CN…”
ResultThe innate immune response in tauopathies
Johnson, A. M., & Lukens, J. R. (2023) · European Journal of Immunology · doi:10.1002/eji.202250266 · Cited by 23
Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders
Rao, Y., & Peng, B. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.02.025 · Cited by 20
“These findings indicate that TREM2 deficiency in mice is not sufficient to phenocopy human NHD [37] .”
BackgroundThe evolution of microglia replacement: A new paradigm for CNS disease therapy
Rao, Y., Bai, Y., Li, X., Du, B., & Peng, B. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.014 · Cited by 27
Wang, Y., Niu, W., Zhu, S., Sun, J., Lv, J., Wang, N., Zhang, H., Zhang, Z., Wang, M., Cao, L., et al. (2024) · Inflammation · doi:10.1007/s10753-024-02029-y · Cited by 19
“Triggering receptor expressed on myeloid cells 2 (TREM2), an innate immune receptor that regulates microglial function, is mainly expressed in microglia [34].”
Self-citationAn in vitro model for studying CNS white matter: functional properties and experimental approaches
Bijland, S., Thomson, G., Euston, M., Michail, K., Thümmler, K., Mücklisch, S., Crawford, C. L., Barnett, S. C., McLaughlin, M., Anderson, T. J., et al. (2019) · F1000Research · doi:10.12688/f1000research.16802.1 · Cited by 19
“, 2009) in a CX 3 CR1-and TREM2-dependent manner (Cantoni et al., 2015; Lampron et al., 2015; Poliani et al., 2015).”
BackgroundDeciphering the heterogeneity of myeloid cells during neuroinflammation in the single‐cell era
Borst, K., & Prinz, M. (2020) · Brain Pathology · doi:10.1111/bpa.12910 · Cited by 17
“For instance, in CPZ-treated TREM2−/− animals, microglia were not activated by myelin lipids, and therefore, did not expand or respond to demyelination, which led to impaired remyelination (22,152).”
BackgroundFunction and mechanism of TREM2 in bacterial infection
Wu, Z., Yang, S., Fang, X., Shu, Q., & Chen, Q. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011895 · Cited by 21
The Role of Microglia in Inherited White-Matter Disorders and Connections to Frontotemporal Dementia
Sirkis, D. W., Bonham, L. W., & Yokoyama, J. S. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s245029 · Cited by 18
The Neuroimmunology of Multiple Sclerosis: Fictions and Facts
Pachner, A. R. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.796378 · Cited by 20
“This molecule appears to be important in the process of myelin debris clearance; TREM2 knockouts have impaired remyelination after cuprizone treatment (168).”
BackgroundIntrinsic organization of the corpus callosum
Barbaresi, P., Fabri, M., Lorenzi, T., Sagrati, A., & Morroni, M. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1393000 · Cited by 21
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients
Krumm, L., Pozner, T., Zagha, N., Coras, R., Arnold, P., Tsaktanis, T., Scherpelz, K. P., Davis, M. Y., Kaindl, J., Stolzer, I., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02675-w · Cited by 18
“In general, DAM occur upon accumulation of neuronal apoptotic bodies and myelin debris, such as in ALS, AD, aging and demyelination [45, 50, 74, 101].”
BackgroundDefective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia
Lee, J. Y., Marian, O. C., & Don, A. S. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08644-4 · Cited by 20
Tan, S., Gao, H., Sun, J., Li, N., Zhang, Y., Yang, L., Wang, M., Wang, Q., & Zhai, Q. (2023) · NeuroMolecular Medicine · doi:10.1007/s12017-023-08733-6 · Cited by 17
The role of microglial TREM2 in development: A path toward neurodegeneration?
Matteoli, M. (2024) · Glia · doi:10.1002/glia.24574 · Cited by 17
“In the same cuprizone model, trem2 (cid:1) / (cid:1) microglia display defective myelin debris clearance, accompanied by oligodendrocyte reduction and persistent demyelination (Cantoni et al., 2015; Poliani et al., 2015).”
InfluentialChatanaka, M. K., Sohaei, D., Diamandis, E. P., & Prassas, I. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2187342 · Cited by 15
“Further abnormalities in TREM2 result in decreased microglial survival in AD mouse models through increased apoptosis [176], and along with its interacting partner DNAX activating protein of 12 kDa (DAP12), they negatively affect the neuronal CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES 405”
BackgroundZhuang, J., Zhang, Y., Shu, H., Zhang, S., Zhao, W., Ward, N., & Wang, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03133-6 · Cited by 19
Liu, L., Liang, J., Liu, Y.-H., Liu, B., Dong, X., Cai, W.-H., & Zhang, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30523 · Cited by 17
“It can detect demyelination by sensing the lipid components of myelin phospholipids and promote the clearance of myelin phospholipid fragments through lipid transport and degradation metabolism [140].”
BackgroundRetractedAshwini, P., Bodhankar, S. L., Muthal, A., Kumar, D., Pawar, A., & Kulkarni, R. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.11.016 · Cited by 19
“The discovery of a TREM2 variation as an AD risk element confirmed the long-held idea that changed microglial activity contributes to the disorder’s etiology 182 .”
Ma, C., Hunt, J. B., Kovalenko, A., Liang, H., Selenica, M. B., Orr, M. B., Zhang, B., Gensel, J. C., Feola, D. J., Gordon, M. N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628156 · Cited by 22
“Lipid pathology has been validated as a shared feature between neurodegenerative mouse models and human AD (63, 117, 118).”
BackgroundGeneration and clearance of myelin debris after spinal cord injury
Li, C., Luo, W., Hussaın, I., Niu, R., He, X., Xiang, C., Guo, F., Liu, W., & Gu, R. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01405 · Cited by 20
“This prolonged retention of myelin debris can lead to the transformation of macrophages to a foamy phenotype, characterized by inadequate lipid efflux, impaired migration, and reduced ability to engulf dying cells (Wang et al., 2015; Van Broeckhoven et al., 2021).”
InfluentialRevisiting the immune landscape post spinal cord injury: More than black and white
Liu, Z.-G., Yang, F., Shi, J., Pengyu, C., Yu, S., & Bo-Yin, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.963539 · Cited by 14
“A study reported that the mutations or deficiencies of TREM2 in the microglia inhibit the uptake and the subsequent phagocytosis of myelin fragments post-SCI (Poliani et al., 2015).”
BackgroundFarzan, M., Rounkian, M. S., Rizi, A. A., Heidari, Z., Farzan, M., Fathi, M., Aghaei, A., Azadegan‐Dehkordi, F., & Bagheri, N. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115071 · Cited by 16
The multicellular interplay of microglia in health and disease: lessons from leukodystrophy
Berdowski, W. M., Sanderson, L. E., & van Ham, T. J. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048925 · Cited by 15
“Loss of functional TREM2 has also been shown to impair the phagocytic capacity of microglia in a range of model systems, including mutant mice (Filipello et al., 2018; Poliani et al., 2015), iPSC-derived microglia (Garcia-Reitboeck et al.”
BackgroundBoudesco, C., Nonneman, A., Cinti, A., Picardi, P., Redaelli, L., Swijsen, S., Roewe, J., Reinhardt, P., Ibach, M., Walter, J., et al. (2022) · Glia · doi:10.1002/glia.24252 · Cited by 15
“…serine (PS) exposed on apoptotic bodies in particular has been proposed by several studies to activate TREM2 (Wang et al., 2015; Kober et al., 2016; Poliani et al., 2015; Shirotani et al., 2019; Cosker et al., 2021; Garcia-Reitboeck et al., 2018) and a cocrystal structure resolved the PS binding…”
BackgroundMethodInfluentialRole of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury
Zhang, C., & Chen, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03094-w · Cited by 14
Label-free assessment of myelin status using birefringence microscopy
Morgan, M. L., Brideau, C., Teo, W., Caprariello, A. V., & Stys, P. K. (2021) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2021.109226 · Cited by 16
Zhang, Y., Shi, Y., Wang, L., Zhao, L., Wang, Y., Yan, J., Sun, X., Luo, Q., & Li, L. (2025) · British Journal of Pharmacology · doi:10.1111/bph.17475 · Cited by 15
“It serves as a major downstream target of the PI3K/Akt pathway and has been shown to influence WMI in conditions such as traumatic brain injury and subarachnoid haemorrhage (Chen et al., 2022; Cross et al., 1995; Wang et al., 2015).”
Self-citationZhang, Y., Nie, R., Feng, Z.-Y., Fan, M., Shen, Z., Zhang, X., Zhang, Q., Zou, C., Zhang, J., Huang, K., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.05.026 · Cited by 27
“…studies that TREM2 receptors on microglial surfaces reduce the release of pro-inflammatory factors such as IL-1 β and TNF-α by mediating NF-κ B pathway inhibition, while simultaneously enhancing phagocytic activity through upregulation of phagocytosis-related gene expression [131,132].”
Physiological and injury-induced microglial dynamics across the lifespan
Tieu, T., Cruz, A.-J. N., Weinstein, J. R., Shih, A. Y., & Coelho‐Santos, V. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115991 · Cited by 16
“22,23 However, microglia may also become senescent or dystrophic, with reduced neuroprotective function, increased pro-inflammatory cytokine release, and decreased anti-inflammatory signaling, contributing to a chronic inflammatory state, neuronal dysfunction, and cell death.”
Myeloid masquerade: Microglial transcriptional signatures in retinal development and disease
Pitts, K. M., & Margeta, M. A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1106547 · Cited by 14
“, 2012) and act as a receptor for myelin debris uptake (Cantoni et al., 2015; Poliani et al., 2015; Wang Y. et al., 2015); however, Safaiyan et al.”
BackgroundThe triggering receptor expressed on myeloid cells 2–apolipoprotein E signaling pathway in diseases
Lyu, S., Lan, Z., & Li, C. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002167 · Cited by 15
“Moreover, ApoE gene knockout causes downregulation of TREM2, DAP12, and lipid metabolismrelated gene expression, which affects neuronal function.([66])Most of the cholesterol in the brain is contained in myelin, so the excessive release of myelin fragments in disease conditions may result in cholesterol accumulation a…”
BackgroundInfluentialCNS macrophage contributions to myelin health
Hoffmann, A., & Miron, V. E. (2024) · Immunological Reviews · doi:10.1111/imr.13416 · Cited by 13
“120, 121 However , TREM2 has an important role in regulating cholesterol cholesterol efflux following less demyelination yet increased abnormal myelin profiles, and poor remyelination.”
Sanchez-Molina, P., Almolda, B., Benseny‐Cases, N., González, B., Perálvarez‐Marín, A., & Castellano, B. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.015 · Cited by 14
Murray, C. J., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119552 · Cited by 13
“A specific population of microglia in the white matter of the aged brain (≥18-months-old), white matter associated microglia (WAM), has an increased expression of triggering receptor expressed on myeloid cells 2 (TREM2)—a receptor important for phagocytosis, lipid metabolism and proper myelination (Poliani et al., 201…”
BackgroundAdult‐onset depletion of sulfatide leads to axonal degeneration with relative myelin sparing
Dustin, E., McQuiston, A. R., Honke, K., Palavicini, J. P., Han, X., & Dupree, J. L. (2023) · Glia · doi:10.1002/glia.24423 · Cited by 11
“(Poliani et al., 2015; Wang et al., 2015; Qiu et al., 2021).”
BackgroundNef mediates neuroimmune response, myelin impairment, and neuronal injury in EcoHIV-infected mice
Schenck, J. K., Paredes, C. C., Pushkarsky, T., Wang, Y., Miller, R. H., & Bukrinsky, M. (2024) · Life Science Alliance · doi:10.26508/lsa.202402879 · Cited by 13
“Although Although further studies on TREM2 distribution are needed for a comprehensive understanding, our fi ndings suggest that EcoHIV infection impacts the TREM2 pathway in a Nef-independent manner.”
InfluentialSelf-citationMicroglia and Multiple Sclerosis
Hammond, B. P., Panda, S. P., Kaushik, D. K., & Plemel, J. R. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_25 · Cited by 11
Microglia in Alzheimer’s Disease: A Favorable Cellular Target to Ameliorate Alzheimer’s Pathogenesis
Sumsuzzman, D. M., Uddin, M. S., Kabir, M. T., Hasana, S., Perveen, A., Alanazi, I. S., Albadrani, G. M., Abdel‐Daim, M. M., & Ashraf, G. M. (2022) · Mediators of Inflammation · doi:10.1155/2022/6052932 · Cited by 12
“Furthermore, TREM2-knockout models show dystrophic microglial cells [201], shortages in microglial survival, and worsening in AD pathology [22].”
BackgroundEnrich-Bengoa, J., Manich, G., Degano, I. R., & Perálvarez‐Marín, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314868 · Cited by 11
Bandow, K., Hasegawa, H., Tomomura, M., & Tomomura, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.045 · Cited by 11
Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression
Domowicz, M. S., Chan, W., Vázquez, P. N. C., Gonzalez, T., & Schwartz, N. B. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02302-z · Cited by 12
“It is also controlled by the TREM activation pathway [58] and has been recognized as a marker of “prime” microglia (pre-activation stage) in aging and ND [68, 69].”
BackgroundHu, Y., & Gao, J. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.104054 · Cited by 10
Research Progress of Lipid Metabolism-Mediated Neuroinflammation in Alzheimer’s Disease
Shen, Y., Wang, X., Liu, X., Wang, G., Hou, X., & Zhou, X. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01648-9 · Cited by 12
“Subgroup analyses suggest expressed on myeloid cells 2 (TREM2), a surface receptor of microglia, regulates microglial chemotaxis, phagocytosis, and survival by binding to DAP12 to form a signaling complex(Poliani et al. 2015; Yeh et al. 2016).”
Lipid-associated macrophages and metabolic inflammatory diseases
Zheng, Y., Tu, D., Dong, C., Zhao, H., & Wang, H. (2026) · Cell Insight · doi:10.1016/j.cellin.2026.100312 · Cited by 14
“…disease-associated microglia (DAMs) surrounding A β plaques of the hippocampal subiculum exhibit similar genes as foam cells in human atherosclerosis, which significantly enrich genes such as CD9 and APOC1 (Claes et al., 2021; Fernandez et al., 2019; Mosher and Wyss-Coray, 2014; Wang et al., 2015).”
InfluentialNovel insights into the role of TREM2 in cerebrovascular diseases
Awuah, W. A., Ben-Jaafar, A., Kong, J. S. H., Sanker, V., Shah, M. H., Poornaselvan, J., Frimpong, M., Imran, S., Alocious, T., Abdul-Rahman, T., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149245 · Cited by 12
“Bone marrow-derived microglia with reduced TREM -2 expression also showed reduced survival following colon stimulating factor 1 ( CSF-1 ) deficiency (Wang et al., 2015).”
Microglial Responses to Alzheimer's Disease Pathology: Insights From “Omics” Studies
Reid, A. N., Jayadev, S., & Prater, K. E. (2025) · Glia · doi:10.1002/glia.24666 · Cited by 10
“While Trem2 − / − mice show expected demyelination in response to cuprizone (CPZ), remyelination is defective in the absence of Trem2 (Cantoni et al. 2015; Poliani et al. 2015).”
Reparative inflammation in multiple sclerosis
Cantuti‐Castelvetri, L., Gökçe, Ö., & Simons, M. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101630 · Cited by 11
Katsumoto, A., Kokiko‐Cochran, O. N., Bemiller, S. M., Xu, G., Ransohoff, R. M., & Lamb, B. T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978423 · Cited by 12
“TREM2 deficiency hindered the accumulation of microglia with abnormalmorphology with age, especially in the corpus callosum, which is rich in myelin thatmay trigger solid TREM2 signaling (18).”
BackgroundAstrocyte signaling and interactions in Multiple Sclerosis
Ortiz, C. K. C., & Eroğlu, Ç. (2023) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2023.102307 · Cited by 17
Perturbed cholesterol homeostasis in aging spinal cord
Parkinson, G. M., Dayas, C. V., & Smith, D. W. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.017 · Cited by 12
Hippocampal Transcriptome Changes After Subarachnoid Hemorrhage in Mice
Regnier‐Golanov, A., Dündar, F., Zumbo, P., Betel, D., Hernandez, M. S., Peterson, L. E., Lo, E. H., Golanov, E. V., & Britz, G. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.691631 · Cited by 9
Siponimod supports remyelination in the non-supportive environment
Krüger, J., Behrangi, N., Schliep, D., Heinig, L., Vankriekelsvenne, E., Wigger, N., & Kipp, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-87825-8 · Cited by 11
Microglia alter sex-specific cerebellar myelination following placental hormone loss
Salzbank, J., Lacaille, H., Gaby, J., O’Reilly, J. J., Kissner, M. D., Vacher, C., & Penn, A. A. (2025) · Nature Communications · doi:10.1038/s41467-025-64814-z · Cited by 12
Xiao, X., Zhang, L. Y., Zhao, H., & Wang, Z. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-025-01161-0 · Cited by 16
Association study between multiple system atrophy and TREM2 p.R47H
Ogaki, K., Heckman, M. G., Koga, S., Martens, Y. A., Labbé, C., Lorenzo‐Betancor, O., Walton, R. L., Soto, A. I., Vargas, E. R., Fujioka, S., et al. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000257 · Cited by 9
“A recent study showed that TREM2 is required for myelin debris removal and remyelination after cuprizone-induced demyelination.(11) We hypothesize that TREM2 p.”
BackgroundMyelin lipid deficiency: a new key driver of Alzheimer’s disease
Han, X., Qiu, S., & Palavicini, J. P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343893 · Cited by 9
Benoit, R. Y., Zagrodnik, J. L., Carew, S. J., & Moore, C. S. (2024) · ImmunoHorizons · doi:10.4049/immunohorizons.2400045 · Cited by 10
Que, X., Zhang, T., Liu, X. Y., Yin, Y., Xia, X., Gong, P., Song, W., Qin, Q., Xu, Q., & Tang, Y. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102732 · Cited by 8
“In the CPZ demyelination model, TREM2 -deficient mice show decreased expression of lipid metabolism genes, resulting in continuous accumulation of lipid droplets in microglial cells (Cantoni et al., 2015; Poliani et al., 2015).”
InfluentialRaffaele, S., Mannella, F. C., Thougaard, E., Nielsen, P. V., Blickfeldt-Eckhardt, M., Tolosa, E., Münsterberg, J., Magnus, T. U., Mikkelsen, J. D., Gelderblom, M., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00745 · Cited by 10
Liao, Y., Mu, G., Deng, S., Lu, B. F., & Zheng, M. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07604-x · Cited by 9
Emerging non-proinflammatory roles of microglia in healthy and diseased brains
Sun, Y., Che, J., & Zhang, J. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110664 · Cited by 11
Ashraf, A., Aljuhani, M., Hubens, C. J., Jeandriens, J., Parkes, H. G., Geraki, K., Mahmood, A., Herlihy, A. H., & So, P. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1393351 · Cited by 11
“TREM2 is pivotal in sustaining trophic functions of microglial in the aging brain (Poliani et al., 2015) and microglial TREM2 expression has been to be reduced in aged mice (Hickman et al., 2013).”
BackgroundHu, S., Pan, N., Liu, C., Wang, Y., & Zhang, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.775432 · Cited by 8
“The number of microglia was lower in various regions of the brain in the TREM2-deficient mice; and this finding was only confirmed in the aging mice (1–2 years old) (Poliani et al., 2015).”
BackgroundSelf-citationThe molecular pathology of neurodegenerative and psychiatric disorders
Yan, P., Deng, Y. M., Su, X., Kong, H., Zhang, Y., Li, W., & Kong, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00007-5 · Cited by 9
Rossi, E., Mracsko, E. Z., Papadimitropoulos, A., Allafi, N., Reinhardt, D., Mehrkens, A., Martín, I., Knuesel, I., & Scherberich, A. (2018) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2018.0061 · Cited by 8
“3,4,18,23 Human 3D organotypic models already proved to be effective in recapitulating the physiological and pathological state of bone.”
Javor, J., Bucová, M., Ďurmanová, V., Radošinská, D., Párnická, Z., Čierný, D., Kurča, E., Čopíková‐Cudráková, D., Gmitterová, K., & Shawkatová, I. (2022) · Life · doi:10.3390/life12071094 · Cited by 8
“The phospholipid-sensing receptor TREM2 is highly expressed by microglia and macrophages in active MS lesions and was shown to promote their survival, proliferation, and phagocytic activity in response to demyelination [16,59,60].”
BackgroundMicroglia clean up toxic lipids in multiple sclerosis
Monroe, K. M., & Paolo, G. D. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00829-1 · Cited by 8
The Role of TREM2 After Stroke: From Mechanisms to Therapeutic Potential
Zhou, T., Chen, A., Sun, Y., Huang, B., Xu, Y., & He, Q. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05622-w · Cited by 7
“A collection of studies underscores the key role of TREM2 and APOE in facilitating the transition to the DAM state, largely controlled by the transcriptional activity of genes associated with lipid metabolism [72, 74, 75].”
Synergistic potential of TREM2 agonists and exercise training in Alzheimer’s disease
Zhang, J., Schneider, B. A., Muguerza, E., Chung, E. K., & Hsu, C. G. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00124.2025 · Cited by 6
The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor
Wang, Y., Chu, Y., Cao, F., Chen, Z., Xu, H., Wang, S., & Ma, J. (2023) · Central European Journal of Immunology · doi:10.5114/ceji.2022.124387 · Cited by 7
Self-citationLipidomics Analysis of Human HMC3 Microglial Cells in an In Vitro Model of Metabolic Syndrome
Chmielarz, M., Bromke, M. A., Olbromski, M., Środa-Pomianek, K., Frej−Mądrzak, M., Dzięgiel, P., & Sobieszczańska, B. (2024) · Biomolecules · doi:10.3390/biom14101238 · Cited by 6
“Hence, our study also examined TREM2 expression as a crucial microglial receptor engaged in taking up glycolipids from the membranes of degraded neuronal processes and myelin debris [52–54].”
BackgroundPrimate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonism
Schauer, S. P., Cho, C. H., Novikova, G., Roth, G. A., Lee, J., Sharma, A. D., Foley, A. R., Ng, C., Shen, P., Choi, M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13921 · Cited by 5
“37 Together, these studies suggest that TREM2 LOF contributes to AD risk, and increasing TREM2 function may represent a potential therapeutic strategy in AD.”
Karsak, M., Glebov, K., Scheffold, M., Bajaj, T., Kawalia, A., Karaca, I., Rading, S., Kornhuber, J., Peters, O., Díez-Fairén, M., et al. (2019) · Human Mutation · doi:10.1002/humu.23904 · Cited by 6
“TREM2 function has been linked to ApoE and loss of TREM2 has been suggested to lead to deficits in lipid sensing important for microglial activation and innate immune responses (Krasemann et al., 2017; Poliani et al., 2015; Shi & Holtzman, 2018; Yeh, Hansen, & Sheng, 2017).”
Guardians of homeostasis: Natural products target metabolic reprogramming in Alzheimer’s disease
Zhang, Z., Xu, H., Zhao, F., Han, Z., Pan, J., Li, M., Guan, W., Jiang, P., Hao, Z., Zhang, Y., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.103005 · Cited by 5
Chen, B., Lu, H.-C., Huang, L., Wang, J., Bujold, M., Tang, L., Du, X., & Wang, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03733-2 · Cited by 6
Self-citationBar, E., Fischer, I., Rokach, M., Elad‐Sfadia, G., Shirenova, S. D., Ophir, O., Trangle, S. S., Okun, E., & Barak, B. (2024) · Glia · doi:10.1002/glia.24519 · Cited by 5
“In disorders involving myelination deficits, microglia may be compromised in their ability to phagocytose myelin debris and support OLs (Bar & Barak, 2019; Poliani et al., 2015).”
BackgroundDicer deficiency affects microglial function during demyelination and impairs remyelination
Tripathi, A. K., Kumar, N., Perles, A., Courtney, H., Jones, C. E., Sapra, A., Plemel, J. R., & Dutta, R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106879 · Cited by 6
“Clearance of myelin debris, followed by recruitment and proliferation of OPCs and differentiation into mature myelinating OLs, are critical steps for successful remyelination in demyelinating diseases like MS (Poliani et al., 2015).”
Yagi, H., Boeck, M., Neilsen, K., Yang, J., Ko, M., Tomita, Y., Negishi, K., Fu, Z., Sun, Y., & Smith, L. E. H. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321809 · Cited by 7
“35,36 We observed that TREM2-positive IBA1 mononuclear phagocytes were minimally detected with immunohistochemistry in the WT-CTRL group.”
The influence of aging and the microbiome in multiple sclerosis and other neurologic diseases
Fettig, N. M., Pu, A., Osborne, L. C., & Gommerman, J. L. (2024) · Immunological Reviews · doi:10.1111/imr.13361 · Cited by 7
“175-177 In addition to their propensity to become hyper-activated upon stimulation and to increase in number, 178,179 the localization of microglia throughout the brain becomes less evenly dispersed, contributing to slower reaction times to stimuli and hindered immune surveillance.”
Bano, N., Khan, S., Ahamad, S., Dar, N. J., Alanazi, H. H., Nazir, A., & Bhat, S. A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00617 · Cited by 6
The Involvement of IL-34 in Inflammatory and Malignant Skin Diseases
Dang, T. V. T., Mehdi, A. M., Kumari, S., Khosrotehrani, K., Frazer, I. H., Hume, D. A., & Chandra, J. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.05.003 · Cited by 8
Altered lipid metabolic homeostasis in the pathogenesis of Alzheimer’s disease
Marian, O. C., Tran, C., & Don, A. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00023-3 · Cited by 5
Xavier, A. M., Distéfano‐Gagné, F., Belhamiti, N., Belhocine, S., Bitarafan, S., Falle, A., Fiola, S., Rivest, S., & Gosselin, D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.04.502805 · Cited by 7
“For example, Trem2 signaling promotes both expression of Itgax mRNA, the gene coding for CD11c and microglia cell population expansion in the CPZ model(50).”
BackgroundThe Function of Microglia in Cognitive Impairment Influenced by Sleep Deprivation
Jiang, J., Li, M., Xia, Y., We, W., Li, S., Wu, X., Li, S., & Xu, H. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01654-x · Cited by 5
“Triggering receptor expressed on myeloid cells 2 (TREM2), a key innate immune receptor involved in microglial regulation, is predominantly found in microglia (Poliani et al. 2015).”
Remyelinating strategies: What can be learned from normal brain development
Shelestak, J., Irfan, M., & DeSilva, T. M. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102290 · Cited by 4
Nies, Y. H., Yahaya, M. F., Lim, W. L., & Teoh, S. L. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230608122552 · Cited by 4
Minimotifs dysfunction is pervasive in neurodegenerative disorders
Sharma, S., Young, R. J., Chen, J., Chen, X., Oh, E. C. T., & Schiller, M. R. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.005 · Cited by 4
“A LOFmutation in the lipid sensing function, a minimotif activity of Trem2 deficient mice may be the underlying mechanism for the loss of microglia proliferation and microglial response to Ab plaques or reduced infiltration of peripheral macrophages [251,252].”
BackgroundTREM2 and Pain Development: An Old Molecule, a New Target
Fan, Z., Huang, C., Li, X., Pan, R., Cai, H., Zhai, X., Ge, Z., & Sun, S. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70188 · Cited by 4
“Its extracellular V-type Ig domain recognizes polyanionic ligands such as phospholipids and lipopolysaccharide (LPS) predominantly through electrostatic interactions (Poliani et al. 2015).”
Alterations in the brain lipidome of Alzheimer's disease donors with rare TREM2 risk variants
Proitsi, P., Ebshiana, A., Wretlind, A., Xu, J., Hodges, A., & Legido‐Quigley, C. (2026) · Brain Communications · doi:10.1093/braincomms/fcaf452 · Cited by 5
“24 It would be therefore possible that individuals without TREM2 risk variants wouldn’t develop AD; however, the impact of common SNP variants on downstream TREM2 function (and hence links to AD pathology) is not fully established.”
Candia, Y. A., Aladyeva, E., Boyden, W., Bollman, B., Rogerson‐Wood, L., Davies, D., Affleck, A. J., Buckland, M. E., Harari, O., Piccio, L. M., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02241-x · Cited by 5
“Clusters 0, 4, 11, 14, 15, and 16 contained a higher proportion of glial cells relative to other clusters associated with neuronal cell types in the hippocampus. d Quantitative analysis of spatial distributions of total TREM2 + spots and TREM2 in relation to selected myeloid cell markers ( CD68,…”
Uemura, K., Hiro, S., Attachaipanich, S., Du, R., Yusof, N. I. S. M., Kinoshita, M., Hikosaka, M., & Ohtsuki, G. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1669272 · Cited by 7
Zelada, D., Saldivia, N., Samano, S., George, D., Chaudhari, K., Nguyen, D. A., Simchuk, D., van Breemen, R. B., & Givogri, M. I. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s523938 · Cited by 3
Metadata
- Authors
- Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M.
- Affiliations
- University of Brescia (IT)
- Washington University in St. Louis (US)
- Corresponding author
- Poliani, Pietro Luigi
- Wang, Yaming
- Colonna, Marco
- Venue
- Journal of Clinical Investigation
- Published
- 2015-04-20
- Volume
- 125
- Issue
- 5
- Pages
- 2161-2170
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4463196
- OpenAlex
- W2094831055
- Cited by
- 525
- References
- 58
- Citations by year
- 2026: 45 · 2025: 41 · 2024: 41 · 2023: 55 · 2022: 69 · 2021: 65 · 2020: 50 · 2019: 43 · 2018: 40 · 2017: 32 · 2016: 32 · 2015: 10
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, public-domain)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Eli Lilly and Company
- Cure Alzheimer's Fund
- Fondazione Cariplo
- National Institutes of Health (5p60dk020579-35, AG005681, DK020579)
- Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis
- Japan Society for the Promotion of Science (15K20969, 26893063)
- RIKEN
- National Institute on Aging (P50AG005681)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK‐020579, P60-DK-020579, P30DK020579)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- TREM2, microglia, aging, demyelination, cuprizone, myelin debris clearance, white matter, oligodendrocyte degeneration, myelin lipids, Nasu-Hakola disease, TREM2 knockout mice, microglial activation, phagocytosis, lipid degradation, axonal dystrophy
- MeSH terms
- Aging, Animals, Axons, Brain, Cell Count, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Humans, Lipodystrophy, Membrane Glycoproteins, Myelin Sheath, Nerve Tissue Proteins, Osteochondrodysplasias, Phagocytosis, Receptors, Immunologic, Regeneration, Subacute Sclerosing Panencephalitis, Transcription, Genetic, Microglia, Genes, Reporter, Mice, Knockout, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.